Financial Consulate, Inc 10x Genomics, Inc. Transaction History

Financial Consulate, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$24.4 - $41.3 $36,966 - $62,569	1,515 Added 0.98%	156,457 $0
Q4 2021 Feb 07, 2022	BUY	$135.05 - $182.59 $45,781 - $61,898	339 Added 0.22%	154,942 $23.1 Million
Q3 2021 Oct 19, 2021	BUY	$145.58 - $192.14 $1.94 Million - $2.56 Million	13,345 Added 9.45%	154,603 $22.5 Million
Q2 2021 Jul 22, 2021	SELL	$134.22 - $202.37 $2.35 Million - $3.54 Million	-17,500 Reduced 11.02%	141,258 $27.7 Million
Q1 2021 Apr 19, 2021	SELL	$140.25 - $196.86 $1.4 Million - $1.97 Million	-10,000 Reduced 5.93%	158,758 $28.7 Million
Q4 2020 Jan 29, 2021	BUY	$126.47 - $163.7 $681,926 - $882,670	5,392 Added 3.3%	168,758 $23.9 Million
Q3 2020 Oct 20, 2020	SELL	$87.44 - $125.0 $2.94 Million - $4.2 Million	-33,572 Reduced 17.05%	163,366 $20.4 Million
Q2 2020 Jul 22, 2020	SELL	$58.39 - $89.31 $621,269 - $950,258	-10,640 Reduced 5.13%	196,938 $17.6 Million
Q1 2020 Apr 29, 2020	BUY	$51.57 - $106.62 $10.7 Million - $22.1 Million	207,578 New	207,578 $12.9 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.48B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.